Published in:
01-07-2020 | SARS-CoV-2 | Commentary
Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA?
Authors:
Bilal Javed, Abdullah Sarwer, Erik B. Soto, Zia-ur-Rehman Mashwani
Published in:
Drugs & Therapy Perspectives
|
Issue 7/2020
Login to get access
Excerpt
The first case of infection with a novel coronavirus was reported in Wuhan, China, in late December 2019. The virus is zoonotic in nature, spreading through human–animal interactions, with the wet seafood markets of Wuhan being considered the breeding grounds of this coronavirus. Initially, the virus was called the Wuhan virus, the bat virus, and 2019-nCoV. On 11 February 2020, after rising in notoriety because of its rapid transmission and dire impact on morbidity and mortality rates, the virus was given the taxonomic nomenclature of “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” by the World Health Organization (WHO); the disease it causes is known as COVID-19 [
1]. The first genome sequence of SARS-CoV-2 was submitted on 12 January 2020 to the US National Center of Biotechnology’s database with ID NC_045512. It showed that SARS-CoV-2 is a 29,903 bp (base pairs) single-stranded RNA coronavirus, with a close resemblance to SARS-CoV and MARS-CoV [
2]. …